Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tsutomu Fukuda

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Bioscience, Biotechnology, and Biochemistry|November 28, 2022
Synthesis and structure-activity relationship study of aldose reductase inhibiting marine alkaloid lukianol A and its derivativesFumito Ishibashi, Shijiao Zha, Taiyo Kondo, et al.
Bioscience, Biotechnology, and Biochemistry|February 12, 2021
Concise synthesis and in vitro anticancer activity of benzo[g][1]benzopyrano[4,3-b]indol-6(13H)-ones (BBPIs), topoisomerase I inhibitors based on the marine alkaloid lamellarinFumito Ishibashi, Tsutomu Fukuda, Shijiao Zha, et al.
Bioorganic & Medicinal Chemistry|November 11, 2011
Synthesis, structure-activity relationships, and mechanism of action of anti-HIV-1 lamellarin α 20-sulfate analoguesHaruka Kamiyama, Yoshinao Kubo, Hironori Sato, et al.
Bioorganic & Medicinal Chemistry|December 17, 2018
Lamellarin-inspired potent topoisomerase I inhibitors with the unprecedented benzo[g][1]benzopyrano[4,3-b]indol-6(13H)-one scaffoldTsutomu Fukuda, Yusuke Nanjo, Masahiro Fujimoto, et al.
Bioorganic & Medicinal Chemistry|November 15, 2017
Design, synthesis, and evaluation of A-ring-modified lamellarin N analogues as noncovalent inhibitors of the EGFR T790M/L858R mutantTsutomu Fukuda, Teppei Umeki, Keiji Tokushima, et al.
Bioorganic & Medicinal Chemistry|February 8, 2021
Synthesis and evaluation of azalamellarin N and its A-ring-modified analogues as non-covalent inhibitors of the EGFR T790M/L858R mutantTsutomu Fukuda, Mizuho Anzai, Akane Nakahara, et al.
Viruses|April 23, 2022
Unique Mode of Antiviral Action of a Marine Alkaloid against Ebola Virus and SARS-CoV-2Mai Izumida, Osamu Kotani, Hideki Hayashi, et al.
Journal of Medicinal Chemistry|August 29, 2013
Synthesis, resolution, and biological evaluation of atropisomeric (aR)- and (aS)-16-methyllamellarins N: unique effects of the axial chirality on the selectivity of protein kinases inhibitionKenyu Yoshida, Ryosuke Itoyama, Masashi Yamahira, et al.
Biological & Pharmaceutical Bulletin|January 3, 2024
Identification of Azalamellarin N as a Pyroptosis InhibitorJun Takouda, Moeka Nakamura, Akane Murasaki, et al.
International Journal of Molecular Sciences|March 14, 2026
Development of a Conditional Replication System Using a Lassa Virus Glycoprotein Complex-Encoding Retroviral Vector for Isolating Resistant Variants to Inhibitors in BSL-2Manya Bakatumana Hans, Anita Moendat Fanto, Tsutomu Fukuda, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Bioscience, Biotechnology, and Biochemistry|November 28, 2022
Synthesis and structure-activity relationship study of aldose reductase inhibiting marine alkaloid lukianol A and its derivativesFumito Ishibashi, Shijiao Zha, Taiyo Kondo, et al.
Bioscience, Biotechnology, and Biochemistry|February 12, 2021
Concise synthesis and in vitro anticancer activity of benzo[g][1]benzopyrano[4,3-b]indol-6(13H)-ones (BBPIs), topoisomerase I inhibitors based on the marine alkaloid lamellarinFumito Ishibashi, Tsutomu Fukuda, Shijiao Zha, et al.
Bioorganic & Medicinal Chemistry|November 11, 2011
Synthesis, structure-activity relationships, and mechanism of action of anti-HIV-1 lamellarin α 20-sulfate analoguesHaruka Kamiyama, Yoshinao Kubo, Hironori Sato, et al.
Bioorganic & Medicinal Chemistry|December 17, 2018
Lamellarin-inspired potent topoisomerase I inhibitors with the unprecedented benzo[g][1]benzopyrano[4,3-b]indol-6(13H)-one scaffoldTsutomu Fukuda, Yusuke Nanjo, Masahiro Fujimoto, et al.
Bioorganic & Medicinal Chemistry|November 15, 2017
Design, synthesis, and evaluation of A-ring-modified lamellarin N analogues as noncovalent inhibitors of the EGFR T790M/L858R mutantTsutomu Fukuda, Teppei Umeki, Keiji Tokushima, et al.
Bioorganic & Medicinal Chemistry|February 8, 2021
Synthesis and evaluation of azalamellarin N and its A-ring-modified analogues as non-covalent inhibitors of the EGFR T790M/L858R mutantTsutomu Fukuda, Mizuho Anzai, Akane Nakahara, et al.
Viruses|April 23, 2022
Unique Mode of Antiviral Action of a Marine Alkaloid against Ebola Virus and SARS-CoV-2Mai Izumida, Osamu Kotani, Hideki Hayashi, et al.
Journal of Medicinal Chemistry|August 29, 2013
Synthesis, resolution, and biological evaluation of atropisomeric (aR)- and (aS)-16-methyllamellarins N: unique effects of the axial chirality on the selectivity of protein kinases inhibitionKenyu Yoshida, Ryosuke Itoyama, Masashi Yamahira, et al.
Biological & Pharmaceutical Bulletin|January 3, 2024
Identification of Azalamellarin N as a Pyroptosis InhibitorJun Takouda, Moeka Nakamura, Akane Murasaki, et al.
International Journal of Molecular Sciences|March 14, 2026
Development of a Conditional Replication System Using a Lassa Virus Glycoprotein Complex-Encoding Retroviral Vector for Isolating Resistant Variants to Inhibitors in BSL-2Manya Bakatumana Hans, Anita Moendat Fanto, Tsutomu Fukuda, et al.
Pageof 3